Published in
Taylor and Francis Group, Leukemia & Lymphoma, 5(53), p. 982-984, 2012
DOI: 10.3109/10428194.2011.643407
Links
Tools
Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice
Journal article published in 2012 by
Hans E. Johnsen,
Corrine Haioun,
Pieternella J. Lugtenburg,
Antonio Salar 
,
Ulrich Jaeger,
Ruth Pettengell,
Francesca G. Rossi,
Gregor Verhoef,
Matthias Schwenkglenks,
Kate Bendall,
Ulrich Duehrsen
,
Ulrich Jaeger,
Ruth Pettengell,
Francesca G. Rossi,
Gregor Verhoef,
Matthias Schwenkglenks,
Kate Bendall,
Ulrich Duehrsen
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 